Revolution Medicines Inc (NAS:RVMD)
$ 40.68 0.9 (2.26%) Market Cap: 6.71 Bil Enterprise Value: 4.95 Bil PE Ratio: 0 PB Ratio: 3.89 GF Score: 50/100

Revolution Medicines Inc at H C Wainwright Global Investment Conference (Virtual) Transcript

Sep 12, 2022 / 11:00AM GMT
Release Date Price: $21.94 (+1.48%)
Robert Burns
HC Wainwright & Co LLC - Analyst

On to our next fireside chat. I'm Robert Burns, the Managing Director, and Senior Biotech Analyst at H.C. Wainwright. I am joined by Mark Goldsmith, the CEO of Revolution Medicines.

Thank you, Mark, for being here today.

Mark Goldsmith
Revolution Medicines Inc - President and CEO

Thanks, Robert. Really appreciate the opportunity.

Robert Burns
HC Wainwright & Co LLC - Analyst

No, of course. So why don't we just dive in. For those who may be unfamiliar with the Revolution Medicines' story? Can you provide a brief high-level overview of the company and your pipeline?

Mark Goldsmith
Revolution Medicines Inc - President and CEO

Sure. Happy to do so. Revolution Medicines is a biotech company focused entirely on RAS-addicted cancers. And that's a really important fundamental statement because by having the entire pipeline focused on the same a biologic area of focus, we developed great leverage in our know-how

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot